Central European Time

Scientific Program

WEDNESDAY, MAY 5, 2021
Breast Cancer

THE 2021 CONFERENCE PROGRAM IS COMPLETELY FREE OF CHARGE!

INTENSIVE WORKSHOP

Breast Surgery Slide and Video Session
Moderation: J.-U. Blohmer and O. Camara

Breast and Axillary Surgery After Neoadjuvant Chemotherapy
J. Heil

Instead of Wire Markers: Types of Seeds
S.Paepke

Robotic Breast Surgery
B. Sarfati

NSME and Implant-based Breast Reconstruction with ADM or Synthetic Meshes
J.-U. Blohmer

Intraoperative Indocyanine Green Angiography (ICG-A)
M. Karsten

Lipofilling Breast Reconstruction
S. Kümmel

Free Flaps in Breast Reconstruction
O. Camara

Surgery of Lymphedema
H. Brorson


BREAK


SATELLITE SYMPOSIUM (supported by Seagen)

Change in the Therapy Landscape at HER2-pos. MBC in the Context of the Current Guidelines – From a German and US-American Perspective
J.-U. Blohmer, S. Kümmel, C. O’Sullivan, A. Schneeweiss


GREETING WORDS

Welcome Address by Prof. Dr. Heyo K. Kroemer,
Chairman of the Executive Board, Charité – Universitätsmedizin Berlin


LOCAL THERPAY OF BREAST CANCER

Chairs: J. Heil, S. Paepke


German Perspective on Current Technical Aspects of Breast Cancer Surgery
S. Kümmel


Charité Perspective on Technical Aspects of Risk-reducing Breast Surgery
J.-U. Blohmer


Breast and Axillary Surgery After Neoadjuvant Chemotherapy
► Mayo Perspective: J.C. Boughey
► German Perspective: J. Heil


Mayo Perspective on Radiotherapy After Implant-based Breast Reconstruction
R.W. Mutter


Discussion


Mayo Perspective on Lymphedema After Breast Cancer Surgery: Prevention, Detection and Treatment
S.A. McLaughlin


MEDICAL ONCOLOGY IN BREAST CANCER THERAPY I

Chairs: S. Kümmel, R.A. Leon Ferre


What Drives Metastases in Breast Cancer?
► American AURORA Program: S. Oesterreich and A. Lee
► German CATCH Program: A. Schneeweiss


Experiences with Patient-derived Xenografts and Cell Cultures and Organoids
► Mayo Perspective: L. Wang
► Charité Perspective: V. Kiver


Role of RNA and DNA Sequencing in Breast Cancer Therapy
U. Keilholz


Biomarkers to Guide Therapy of Breast Cancer Patients
► Mayo Perspective: J.M. Carter
► German Perspective: N. Harbeck


MEDICAL ONCOLOGY IN BREAST CANCER THERAPY II

Chairs: D. Speiser, K. J. Ruddy


Presidential Lecture:
Endocrine Resistance in Early and Advanced Breast Cancer and Treatment Options After Tumor Progression under CDK4/6 Inhibition

M. P. Goetz


Immunotherapy for Whom and When?
► Mayo Perspective: R. A. Leon Ferre
► German Perspective: G. Pecher


Charité Perspective on HRD-related Therapies
D. Speiser


MEDICAL ONCOLOGY IN BREAST CANCER THERAPY III

Chairs: M.P. Goetz, M. Karsten


Indications, Options, Algorithms in HER2+ Breast Cancer Therapy Today
J. Huober


Mayo Perspective on Prevention of Breast Cancer
A.C. Degnim


PATIENT REPORTED OUTCOME MEASURES IN BREAST CANCER THERAPY

Chairs: A.C. Degnim, U. Keilholz


PROMs in Medical Oncology: A New Study Endpoint / Management of Side Effects of Modern Drugs in Medical Oncology
► Mayo Perspective: K. J. Ruddy


PROMs in Breast Cancer Surgery and Follow-up
► Charité Perspective: M. Karsten


Summary of the Day
M.P. Goetz and J.-U. Blohmer



Afterwards:

Wappen

BERLIN CULTURAL HIGHLIGHT OF THE DAY

with Dr. med. Negin Karimian, Dermatologist and Singer

Fireside

FIRESIDE CHAT

with Prof. Dr. med. Werner Lichtenegger, Berlin (D)